a.cabrera
TL2 Moderator · Aarhus
Contributes reviews on supplier material. Based in Aarhus.
Joined 8 November 2024 · last posted 2d
86 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #90 · Compounds › Cagrilintide & amylin analogues · 26 Jul 2026 · 19 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Which categories are strict and which are relaxed, honestly Replied, post #46 · Start Here › Welcome · 24 Jul 2026 · 6 likes Picking up post #43: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Transit times by route, from a logged dataset Replied, post #31 · Sourcing › Logistics · 24 Jul 2026 · 5 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #26 · Clinical › Prescriber conversations · 21 Jul 2026 · 16 likes This follows post #23 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #10 · Compounds › Tirzepatide · 13 Jul 2026 · 13 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #115 · Practice › Reconstitution · 8 Jul 2026 · 7 likes I read post #113 twice before replying, because I had assumed the opposite. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
-
Shoulders, tangent skims, and defensible integration Replied, post #14 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 16 likes post #13 answers the question as asked. The question underneath it is different. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar…
-
How to ask a question when you cannot say why you are asking it Replied, post #18 · Start Here › How to Ask · 20 Jun 2026 · 26 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #38 · Analytics › Mass spectrometry · 15 Jun 2026 · 10 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
CJC-1295 with and without DAC: what the modification does Replied, post #84 · Compounds › Secretagogues & GH axis · 15 Jun 2026 · 28 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
Injecting into an area that has become firm: why not to Replied, post #69 · Practice › Administration · 14 Jun 2026 · 17 likes On post #65 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Tracking a shortage from primary sources rather than rumour Replied, post #46 · Access › Shortages · 11 Jun 2026 · 0 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #71 · Practice › Reconstitution · 4 Jun 2026 · 5 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Insurance and replacement policies, compared Replied, post #3 · Sourcing › Logistics · 3 Jun 2026 · 0 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #36 · Wellbeing › Sleep · 16 May 2026 · 20 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #38 · Analytics › COA interpretation · 4 May 2026 · 19 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The "under review" status pill and when a moderator applies it Replied, post #99 · Evidence › Preprints · 27 Apr 2026 · 15 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Sample handling between despatch and injection Replied, post #69 · Analytics › Method validation · 26 Apr 2026 · 6 likes Worth separating two things that post #65 runs together. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background.…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #104 · Practice › Storage & stability · 24 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #106 · Analytics › Mass spectrometry · 23 Apr 2026 · 25 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Official shortage notices and what they authorise Replied, post #12 · Access › Shortages · 19 Apr 2026 · 0 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #66 · Data & Tools › Calculators · 10 Apr 2026 · 9 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #142 · Access › Pricing · 10 Apr 2026 · 1 like International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Fasting versus non-fasting and which tests care Replied, post #7 · Clinical › Bloodwork · 3 Apr 2026 · 33 likes Coming back to post #5, because the follow-up matters more than the original answer. TSH and free hormones: TSH is a reasonable screening test but does not tell you…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #16 · Evidence › Trials · 21 Mar 2026 · 18 likes post #15 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #39 · Access › International · 11 Mar 2026 · 10 likes I read post #37 twice before replying, because I had assumed the opposite. Country-by-country legality: compound approval and legal status differ substantially by…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #32 · Compounds › Tirzepatide · 3 Mar 2026 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #5 · Research Methods › N-of-1 designs · 20 Feb 2026 · 0 likes This follows post #2 rather than contradicting it. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #100 · Practice › Dosing & titration · 20 Feb 2026 · 22 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #5 · Practice › Dosing & titration · 14 Feb 2026 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #12 · Practice › Reconstitution · 13 Feb 2026 · 2 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #115 · Compounds › Semaglutide · 9 Feb 2026 · 0 likes Worth separating two things that post #111 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
What a certificate commits its issuer to — one year on Replied, post #13 · Analytics › COA interpretation · 4 Feb 2026 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Hepatic impairment and the absence of data — a second dataset Started this topic · Clinical › Special populations · 2 Feb 2026 · 47 likes On the subject in the title: Hepatic impairment and the absence of data — a second dataset Working notes rather than a conclusion. Asking about a population rather than…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Started this topic · Analytics › Mass spectrometry · 2 Feb 2026 · 16 likes Posting this under the heading it deserves: MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Everything below is what sits behind…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #104 · Analytics › Home & field testing · 12 Jan 2026 · 3 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #10 · Analytics › COA interpretation · 9 Jan 2026 · 3 likes This follows post #7 rather than contradicting it. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a…
-
Waist circumference technique and its repeatability Replied, post #16 · Outcomes › Progress reports · 14 Nov 2025 · 18 likes Coming back to post #14, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #30 · Sourcing › Regulatory · 6 Nov 2025 · 0 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Where the integrator drew the baseline, and how much it moved the number Replied, post #18 · Analytics › HPLC & UHPLC · 6 Nov 2025 · 9 likes Worth separating two things that post #14 runs together. Method validation is the demonstration that a method can separate the compound from its degradation products…
-
Journal club: LEADER as the historical anchor Replied, post #2 · Evidence › Journal club · 5 Nov 2025 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #89 · Analytics › Home & field testing · 4 Nov 2025 · 5 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
EMA product information as a primary source Replied, post #19 · Regional › European Union · 31 Oct 2025 · 7 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #132 · Compounds › Tirzepatide · 25 Oct 2025 · 5 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #89 · Compounds › Tirzepatide · 23 Oct 2025 · 24 likes post #88 answers the question as asked. The question underneath it is different. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #94 · Start Here › Welcome · 21 Oct 2025 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #7 · Compounds › Semaglutide · 8 Sep 2025 · 0 likes Worth separating two things that post #3 runs together. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #44 · Evidence › Preprints · 24 Aug 2025 · 0 likes post #43 is right about the mechanism and I think understates the practical bit. Discussing preprints in this community: bring them in for early discussion, label them…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #42 · Analytics › Mass spectrometry · 20 Aug 2025 · 3 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Follow-up: Why appetite effects are mostly central Replied, post #18 · Pharmacology › Receptor biology · 15 Aug 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #15 · Wellbeing › Mental health · 12 Aug 2025 · 1 like Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Coming back to: When "no data" is the complete and final answer Replied, post #78 · Compounds › Other compounds · 9 Aug 2025 · 29 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Antibiotics and a course of something with delayed emptying Replied, post #98 · Practice › Interactions · 23 Jul 2025 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
A field-by-field walk through a certificate of analysis Replied, post #106 · Analytics › COA interpretation · 17 Jul 2025 · 31 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #21 · Compounds › Semaglutide · 1 Jul 2025 · 0 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #23 · Analytics › Method validation · 25 Jun 2025 · 20 likes Worth separating two things that post #19 runs together. Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH,…
-
Managing an unplanned gap in supply — what changed since Replied, post #5 · Access › Shortages · 22 Jun 2025 · 5 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #38 · Compounds › Repair & healing peptides · 13 Jun 2025 · 28 likes Worth separating two things that post #34 runs together. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific…
-
Titles that describe the question, not the situation Replied, post #26 · Start Here › How to Ask · 11 Jun 2025 · 4 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Reading an MS report that only gives you a single number Replied, post #95 · Analytics › Mass spectrometry · 1 Jun 2025 · 26 likes Worth separating two things that post #91 runs together. What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #111 · Access › Pricing · 23 May 2025 · 0 likes I read post #109 twice before replying, because I had assumed the opposite. Biosimilars and future generics: as patents expire, biosimilar and generic versions might…
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #6 · Sourcing › Payments · 26 Apr 2025 · 4 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #20 · Compounds › Repair & healing peptides · 18 Apr 2025 · 32 likes post #19 is right about the mechanism and I think understates the practical bit. Stability of BPC-157 in solution: what has been measured in published work covers…
-
A certificate with no method stated: what can you conclude? Replied, post #33 · Analytics › COA interpretation · 5 Apr 2025 · 6 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Adjudicated events and why the definition matters — the long version Replied, post #78 · Evidence › Trials · 2 Apr 2025 · 16 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #73 · Sourcing › Red flags · 31 Mar 2025 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #30 · Outcomes › Progress reports · 22 Mar 2025 · 13 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #147 · Sourcing › Regulatory · 6 Mar 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #65 · Access › International · 25 Feb 2025 · 12 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Distinguishing a deletion sequence by mass alone Replied, post #44 · Analytics › Mass spectrometry · 3 Feb 2025 · 9 likes post #43 is right about the mechanism and I think understates the practical bit. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #24 · Evidence › Meta-analyses · 29 Jan 2025 · 12 likes I read post #22 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #70 · Analytics › COA interpretation · 28 Jan 2025 · 0 likes Picking up post #67: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Fibre intake when total intake falls, and the constipation link Replied, post #20 · Nutrition & Training › Protein & intake · 23 Jan 2025 · 15 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #28 · Pharmacology › Receptor biology · 18 Jan 2025 · 11 likes post #27 is right about the mechanism and I think understates the practical bit. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is…
-
Body image changing more slowly than the body Replied, post #117 · Wellbeing › Mental health · 24 Dec 2024 · 3 likes Coming back to post #115, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #5 · marked as the solution · Compounds › Semaglutide · 21 Dec 2024 · 8 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #22 · Data & Tools › Calculators · 17 Dec 2024 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Building a sensible monitoring schedule with your prescriber Replied, post #5 · Clinical › Bloodwork · 17 Dec 2024 · 19 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #109 · Compounds › Repair & healing peptides · 21 Nov 2024 · 0 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #7 · Clinical › Special populations · 19 Nov 2024 · 0 likes Worth separating two things that post #3 runs together. Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but…
-
Buffers, pH and why a formulation is a formulation Replied, post #16 · Pharmacology › Formulation chemistry · 31 Oct 2024 · 4 likes Worth separating two things that post #12 runs together. Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system (phosphate, Tris, or…
-
Irish differences from the UK position Replied, post #55 · Regional › UK & Ireland · 24 Oct 2024 · 17 likes Coming back to post #53, because the follow-up matters more than the original answer. Importing for personal use: importing a prescription-only medicine without a…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #59 · Compounds › Semaglutide · 18 Sep 2024 · 5 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #4 · Nutrition & Training › Protein & intake · 4 Sep 2024 · 27 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Progressive overload when the scale is falling — one year on Replied, post #26 · Nutrition & Training › Resistance training · 4 Sep 2024 · 1 like Cardio and resistance: the interaction between energy-intense cardiovascular training and resistance training is real. Moderate cardio is fine; excessive endurance…
-
The mass-error checker and its intended scope Replied, post #108 · Data & Tools › Calculators · 8 Jul 2024 · 2 likes I read post #106 twice before replying, because I had assumed the opposite. Titration planning: a calculator that shows you the escalation schedule for different…